Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations

Genomics

Volumn 58, Issue 3, 1999, Pages 310-312

  Marsh, Sharon ^a   Collie Duguid, Elaina S R ^a   Li, Tao ^b,c   Liu, Xiehe ^c   McLeod, Howard L ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Asian; Ethnic groups; Pharmacogenetics; Polymorphism; Thymidylate synthase

Indexed keywords

PYRIMIDINE; THYMIDYLATE SYNTHASE;

ARTICLE; ASIAN; CANCER CHEMOTHERAPY; CAUCASIAN; CHINESE; DNA POLYMORPHISM; DNA SYNTHESIS; DRUG TARGETING; ENHANCER REGION; ENZYME ACTIVITY; ETHNIC DIFFERENCE; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INDIVIDUALIZATION; INHERITANCE; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; TANDEM REPEAT;

EID: 0033564283     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1999.5833     Document Type: Article

References (11)

1. Rustum Y. M., Harstrick A., Cao S., Vanhoefer U., Yin M. B., Wilke H., Seeber S. Thymidylate synthase inhibitors in cancer therapy: Direct and indirect inhibitors. J. Clin. Oncol. 15:1997;389-400.
2. Leichman C. G., Lenz H. J., Leichman L., Danenberg K., Baranda J., Groshen S., Boswell W., Metzger R., Tan M., Danenberg P. V. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J. Clin. Oncol. 15:1997;3223-3229.
3. Horie N., Takeishi K. Identification of functional elements in the promoter region of the human gene for thymidylate synthase and nuclear factors that regulate the expression of the gene. J. Biol. Chem. 272:1997;18375-18381.
4. Horie N., Aiba H., Oguro K., Hojo H., Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct. Funct. 20:1995;191-197.
5. Kaneda S., Takeishi K., Ayusawa D., Shimizu K., Seno T., Altman S. Role in translation of a triple tandemly repeated sequence in the 5′-untranslated region of human thymidylate synthase mRNA. Nucleic Acids Res. 15:1987;1259-1270.
6. Collie-Duguid E. S. R., Pritchard S. C., Powrie R. H., Sludden J., Collier D. A., Li T., McLeod H. L. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics. 9:1999;37-42.
7. McLeod H. L., Syvänen A.-C., Githangá J., Indalo A., Ismail D., Dewar K., Ulmanen I., Sludden J. Ethnic differences in catechol-O-methyltransferase pharmacogenetics: Frequency of the codon 108/158 low activity allele is lower in Kenyan than Caucasian or South-west Asian individuals. Pharmacogenetics. 8:1998;195-199.
8. Li T., Vallada H., Curtis D., Arranz M., Xu K., Cai G., Deng H., Liu J., Murray R., Liu X., Collier D. A. Catechol-O-methyltransferase Val158Met polymorphism: Frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics. 7:1997;349-353.
9. Hammer M. F., Karafet T., Rasanayagam A., Wood E. T., Altheide T. K., Jenkins T., Griffiths R. C., Templeton A. R., Zegura S. L. Out of Africa and back again: Nested cladistic analysis of human Y chromosome variation. Mol. Biol. Evol. 15:1998;427-441.
10. Cavalli-Sforza L. L. The DNA revolution in population genetics. Trends Genet. 14:1998;60-65.
11. Fernandez-Salguero P., Hoffman S. M., Cholerton S., Mohrenweiser H., Raunio, Rautio A., Pelkonen O., Huang J. D., Evans W. E., Idle J. R. A genetic polymorphism in coumarin 7-hydroxylation: Sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am. J. Hum. Genet. 57:1995;651-660.